1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. AUROBINDO PHARMA LTD.
Aurobindo Pharma Ltd. Ask MarketMind AI v1.5
NSE: AUROPHARMA | BSE: 524804

Aurobindo Pharma Live Share Price Today, Share Analysis and Chart

Turnaround Potential
In 4 Starfolio Baskets
Iran war impact

The impact of the ongoing conflict and the closure of the Strait of Hormuz on Aurobindo Pharma Ltd. (AUROPHARMA) is characterized by minimal direct revenue risk but significant indirect operational headwinds related to supply chain costs ...

Read More
1291.40 43.90 (3.52%)
Near 52W High of ₹1319.80
1.4M
NSE+BSE Volume

NSE 20 Mar, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
US FDA Observation
Aurobindo Pharma's arm, Apitoria Pharma, receives Form 483 with three observations from the US FDA See details
Loading... You have run out of DVM views!
Subscribe now to see details
Durability score
Medium Financial Strength
- / 100
Valuation Score
Mid Valuation
- / 100
Momentum Score
Technically Moderately Bullish
68.2 / 100
Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM
Analyst Price Target
1,338
1Yr Price target upside is 4%
26 analysts

27

S

3

W

3

O

2

T

SWOT Analysis

Aurobindo Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
Is Aurobindo Pharma Ltd. worth buying?
1264 Votes:
Buy 80.3%
Sell 13.69%
Hold 6.01%
BUY
SELL
HOLD
AI